Skip to content

Zoetis

US · ZTS #700 by market cap Listed 1970
79.11 -1.68 -2.08%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:41

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 37 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.5 percentage points.

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
98.20% -0.50pp
Institutions
1,783 -37
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund75.11%
Private Company7.44%
Public Company5.28%
Hedge Fund5.11%
Government Pension Fund2.27%
Sovereign Wealth Fund1.16%
Family Office/Trust0.54%
VC/PE Fund0.47%
Insurance Company0.40%
Other2.22%

Top holders as of 2026-06-30

BlackRock 9.54% · 39.43M sh
Vanguard Capital Management, LLC 6.87% · 28.39M sh
Vanguard Portfolio Management, LLC 5.77% · 23.86M sh
State Street Global Advisors 4.76% · 19.67M sh
State Farm Mutual Automobile Insurance Company 3.85% · 15.89M sh
Geode Capital Management, LLC 3.21% · 13.27M sh
Wellington Management Group 2.28% · 9.42M sh
UBS Asset Management 1.83% · 7.57M sh
Nordea Investment Management AB 1.60% · 6.59M sh
Deutsche Asset & Wealth Management 1.39% · 5.74M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 41 buys · 5 sells

NameRoleStake
Kristin Peck Chief Executive Officer 0.03%
Michael McCAllister Independent Non-Executive Chairperson 0.01%
Heidi Chen Former Employee Advisor 0.01%
Robert Scully Former Independent Director 0.01%
Louise Parent Former Independent Director 0.01%
Paul Bisaro Independent Director 0.01%
Wetteny Joseph Special Advisor to the CEO 0.01%
Frank D'Amelio Independent Director 0.01%
Gregory Norden Independent Director 0.00%
Roxanne Lagano General Counsel 0.00%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-29 Mark Stetter Independent Director Other Derivative Acquisition +5 --
2026-10-08 Kristin Peck Chief Executive Officer Other Derivative Acquisition +720 --
2026-10-08 Roxanne Lagano General Counsel Other Derivative Acquisition +367 --
2026-10-08 Abhay Nayak Executive VP & President of U.S. Commercial Operations Other Derivative Acquisition +321 --
2026-10-08 Julie Fuller Executive VP, Chief Human Resources Officer & Global Operations Other Derivative Acquisition +367 --
2026-10-08 Jeannette Astorga Executive VP of Corporate Affairs & Chief Sustainability Officer Other Derivative Acquisition +52 --
2026-10-08 Rimma Driscoll EVP of Global Strategy, Portfolio Mkt, Busi. Dev Human Health and Platinum Per. Other Derivative Acquisition +277 --
2026-10-08 Keith Sarbaugh Executive VP & Chief Digital and Technology Officer Other Derivative Acquisition +303 --
2026-10-08 Kevin Esch Executive VP and President of Research & Development Other Derivative Acquisition +360 --
2026-09-29 Julie Fuller Executive VP, Chief Human Resources Officer & Global Operations Derivative Exercise and Sale -274 $69.83
2026-09-29 Julie Fuller Executive VP, Chief Human Resources Officer & Global Operations Derivative Exercise and Retained +525 --
2026-09-16 Mark Stetter Independent Director Other Derivative Acquisition +342 --
2026-08-30 James Saccaro Chief Financial Officer Other Derivative Acquisition +81,063 --
2026-08-06 Frank D'Amelio Independent Director Other Disposition -6,650 --
2026-07-09 Wetteny Joseph Special Advisor to the CEO Other Derivative Acquisition +363 --
2026-07-09 Kristin Peck Chief Executive Officer Other Derivative Acquisition +616 --
2026-07-09 Roxanne Lagano General Counsel Other Derivative Acquisition +314 --
2026-07-09 Abhay Nayak Executive VP & President of U.S. Commercial Operations Other Derivative Acquisition +214 --
2026-07-09 Julie Fuller Executive VP, Chief Human Resources Officer & Global Operations Other Derivative Acquisition +314 --
2026-07-09 Jeannette Astorga Executive VP of Corporate Affairs & Chief Sustainability Officer Other Derivative Acquisition +45 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:41:38 · For reference only, not investment advice and not tailored to your situation.

Zoetis discussion 0 comments

Add a comment